Bextra, manufactured by Pfizer, is another COX-2 inhibitor painkiller used to treat osteoarthritis, rheumatoid arthritis, and menstrual cramps.
Similar to the other COX-2 drugs, Vioxx and Celebrex, Bextra has been shown to increase the risk of heart attack and stroke. However, Bextra presents the risk of Stevens Johnson Syndrome. Stevens Johnson Syndrome is a skin hypersensitivity disorder. This is a potentially life threatening disorder, characterized by ulcerated lesions on the skin and mucous membranes. Symptoms of SJS include painful blistering of the skin, lesions along the mouth that could possibly prevent eating, or a discharge of pus from the eye.
On April 7, 2005, the U.S. Food and Drug Administration asked Pfizer to pull Bextra from the market because, "the overall risk versus benefit profile for (Bextra) is unfavorable."
Bextra lawyers across the country have begun organizing class action suits against Pfizer. If you were prescribed Bextra and subsequently experienced any of the drug's side effects, contact us today to evaluate your claim.
Do you need more information or would like to talk with a Stipe Law Firm professional? Click here to get more information.
